Tagged: Flu pandemic

Glaxo bets on pandemics

British pharmaceutical giant GlaxoSmithKline PLC has spent more than $3.2 billion over the past five years on research and acquisitions¬†specifically related to an anticipated flu pandemic.¬† Now comes the payoff as the swine flu sweeps the world.¬† Law Professor Kevin Outterson, head of the Health Law Program and an authority on drug marketing, said Glaxo […]